Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial

Fizazi, Karim, Massard, Christophe, Bono, Petri, Jones, Robert, Kataja, Vesa, James, Nicholas, Garcia, Jorge A, Protheroe, Andrew, Tammela, Teuvo L, Elliott, Tony, Mattila, Leena, Aspegren, John, Vuorela, Annamari, Langmuir, Peter and Mustonen, Mika 2014. Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial. Lancet Oncology 15 (9) , pp. 975-985. 10.1016/S1470-2045(14)70240-2

[img]
Preview
PDF - Accepted Post-Print Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (803kB) | Preview
Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Elsevier: Lancet
ISSN: 1470-2045
Date of First Compliant Deposit: 8 March 2019
Date of Acceptance: 23 June 2014
Last Modified: 25 Mar 2019 11:30
URI: http://orca.cf.ac.uk/id/eprint/120395

Citation Data

Cited 101 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics